Schrödinger, Inc. (SDGR)
NASDAQ: SDGR · Real-Time Price · USD
18.53
-0.68 (-3.54%)
Aug 11, 2025, 11:11 AM - Market open
Paramount Global Employees
Schrödinger had 891 employees as of December 31, 2024. The number of employees increased by 24 or 2.77% compared to the previous year.
Employees
891
Change (1Y)
24
Growth (1Y)
2.77%
Revenue / Employee
$267,022
Profits / Employee
-$203,516
Market Cap
1.36B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 891 | 24 | 2.77% |
Dec 31, 2023 | 867 | 80 | 10.17% |
Dec 31, 2022 | 787 | 123 | 18.52% |
Dec 31, 2021 | 664 | 212 | 46.90% |
Dec 31, 2020 | 452 | 58 | 14.72% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
SDGR News
- 4 days ago - Schrödinger, Inc. (SDGR) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 4 days ago - Schrödinger Reports Second Quarter 2025 Financial Results - Business Wire
- 17 days ago - Schrödinger to Announce Second Quarter 2025 Financial Results on August 6 - Business Wire
- 24 days ago - Material Informatics Company Evaluation Report 2025 | Schrodinger, Dassault Systèmes, and Citrine Informatics Drive Market Growth Through AI, Simulation, and Collaboration - GlobeNewsWire
- 24 days ago - Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) - Business Wire
- 25 days ago - Ajax Therapeutics and Schrödinger Expand Research Collaboration to Include Additional JAK Target - Business Wire
- 6 weeks ago - Schrödinger Receives Fast Track Designation for SGR-1505 for the Treatment of Relapsed/Refractory Waldenström Macroglobulinemia - Business Wire
- 2 months ago - Schrödinger: Assessing The Signal And The Noise In The Phase 1 Results - Seeking Alpha